BRWM
ONCT

B. Riley Wealth Management’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

B. Riley Wealth Management’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7
Closed -$13K – 798
2015
Q2 		$13K Hold
7
– – 0.01% 699
2015
Q1 		$6K Hold
7
– – ﹤0.01% 839
2014
Q4 		$6K Hold
7
– – ﹤0.01% 827
2014
Q3 		$6K Hold
7
– – ﹤0.01% 881
2014
Q2 		$12K Hold
7
– – 0.01% 787
2014
Q1 		$14K Buy
+7
New +$17.4K 0.01% 705

Other funds holding ONCT

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FHA
First Horizon Advisors Memphis, Tennessee $3.85B AUM 16.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

B. Riley Wealth Management's ONCT Position: Q3 2015 in Review

B. Riley Wealth Management sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q3 2015, closing a stake of 7 shares — an estimated $13K sold.

B. Riley Wealth Management first reported a position in ONCT in Q1 2014 and held it in 6 quarters. The position peaked at $14K in Q1 2014. 38 funds tracked by Wall St. Rank hold ONCT as of Q3 2015.

  • B. Riley Wealth Management reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • B. Riley Wealth Management sold 7 Oncternal Therapeutics, Inc. Common Stock shares in Q3 2015, an estimated $13K.
  • B. Riley Wealth Management first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2014 and held it in 6 quarters.
  • B. Riley Wealth Management's Oncternal Therapeutics, Inc. Common Stock position peaked at $14K in Q1 2014.
  • 38 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q3 2015.

Based on B. Riley Wealth Management's 13F filing for Q3 2015, filed 13 Oct 2015.